These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 2714423

  • 1. In vivo effects of recombinant human erythropoietin on circulating human hemopoietic progenitor cells.
    Ganser A, Bergmann M, Völkers B, Grützmacher P, Scigalla P, Hoelzer D.
    Exp Hematol; 1989 Jun; 17(5):433-5. PubMed ID: 2714423
    [Abstract] [Full Text] [Related]

  • 2. The effect of recombinant human erythropoietin on circulating hematopoietic progenitor cells in anemic premature infants.
    Meister B, Maurer H, Simma B, Kern H, Ulmer H, Hittmair A, Fink FM.
    Stem Cells; 1997 Jun; 15(5):359-63. PubMed ID: 9323798
    [Abstract] [Full Text] [Related]

  • 3. In vivo effects of recombinant human erythropoietin on bone marrow hematopoiesis in patients with chronic renal failure.
    Biljanović-Paunović L, Djukanović L, Lezaić V, Stojanović N, Marisavljević D, Pavlović-Kentera V.
    Eur J Med Res; 1998 Dec 16; 3(12):564-70. PubMed ID: 9889177
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effects of recombinant human erythropoietin on hematopoietic progenitors of chronic hemodialysis patients in vitro and in vivo.
    Hino M, Miyazono K, Urabe A, Takaku F.
    Int J Cell Cloning; 1989 Jul 16; 7(4):257-63. PubMed ID: 2768843
    [Abstract] [Full Text] [Related]

  • 6. Growth characteristics of circulating hematopoietic progenitors in terminal renal failure.
    Glaser M.
    Med Sci Monit; 2006 Mar 16; 12(3):CR113-7. PubMed ID: 16501421
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparative analysis of the influences of human gamma, alpha and beta interferons on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells.
    Broxmeyer HE, Lu L, Platzer E, Feit C, Juliano L, Rubin BY.
    J Immunol; 1983 Sep 16; 131(3):1300-5. PubMed ID: 6193183
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Circulating CFU-E during hematopoietic recovery after allogeneic bone marrow transplantation: relationship to erythroid engraftment.
    Vannucchi AM, Bosi A, Lombardini L, Grossi A, Bacci P, Guidi S, Saccardi R, Rossi-Ferrini P.
    Exp Hematol; 1995 Dec 16; 23(13):1337-40. PubMed ID: 7498360
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
    Lemoli RM, Gulati SC.
    Stem Cells; 1993 Sep 16; 11(5):435-44. PubMed ID: 7694721
    [Abstract] [Full Text] [Related]

  • 16. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM, Fortuna A, Fogli M, Gherlinzoni F, Rosti G, Catani L, Gozzetti A, Miggiano MC, Tura S.
    Exp Hematol; 1995 Dec 16; 23(14):1520-6. PubMed ID: 8542941
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Studies of W mutant mice provide evidence for alternate mechanisms capable of activating hematopoietic stem cells.
    Miller CL, Rebel VI, Lemieux ME, Helgason CD, Lansdorp PM, Eaves CJ.
    Exp Hematol; 1996 Feb 16; 24(2):185-94. PubMed ID: 8641340
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Growth characteristics of marrow hematopoietic progenitor/precursor cells from patients on a phase I clinical trial with purified recombinant human granulocyte-macrophage colony-stimulating factor.
    Broxmeyer HE, Cooper S, Williams DE, Hangoc G, Gutterman JU, Vadhan-Raj S.
    Exp Hematol; 1988 Aug 16; 16(7):594-602. PubMed ID: 3260558
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.